Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old

Publication Date: July 31, 2021
Last Updated: July 24, 2022

Summary of Key Action Statements

Infants 8 to 21 d of age (KASs 1-7): Clinicians… 

 KAS 1: Should obtain urine specimen by catheterization or suprapubic aspiration (SPA) of bladder for urinalysis and, if urinalysis result is positive, for culture.

(A, Strong)
328602

 KAS 2: Should obtain a blood culture.

(A, Strong)
328602

 KAS 3: May assess inflammatory markers (IMs).

(B, Weak)
328602

 KAS 4: Should obtain CSF for analysis (WBC, protein, glucose, Gram stain) and culture for bacteria. See notes for viral testing.

(A, Strong)
328602

 KAS 5: Should initiate parenteral antimicrobial therapy.

(A, Strong)
328602

 KAS 6: Should actively monitor infants while awaiting results of bacterial cultures in a hospital setting with nurses and staff experienced in the care of neonates/young infants.

(B, Moderate)
328602

 KAS 7a: Should discontinue parenteral antimicrobial agents and discharge hospitalized patients when all of the following criteria are met: (1) culture results are negative for 24–36 h or only positive for contaminants; (2) the infant continues to appear clinically well or is improving (eg, fever, feeding); (3) tare no other reasons for hospitalization.

(B, Strong)
328602

 KAS 7b: Should treat infants’ positive bacterial pathogens in urine, blood, or CSF with targeted antimicrobial therapy for the duration of time consistent with the nature of the disease, responsible organism, and response of the infant to treatment.

(A, Strong)
328602

Overview

Title

Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old

Authoring Organization

American Academy of Pediatrics